CHILE

SHINE Technologies to Exhibit at 7th Annual Theranostics World Congress

Retrieved on: 
Monday, March 18, 2024

JANESVILLE, Wis., March 18, 2024 /PRNewswire/ -- SHINE Technologies, a leader in medical isotope production, will showcase its innovative capabilities for producing non-carrier-added lutetium-177 (n.c.a Lu-177), a radioisotope used in targeted cancer treatments, at the 7th Theranostic World Congress (TWC), March 22-24 in Santiago, Chile. Attendees are invited to visit Booth A13 to learn about SHINE's production capabilities at its Cassiopeia facility.

Key Points: 
  • JANESVILLE, Wis., March 18, 2024 /PRNewswire/ -- SHINE Technologies, a leader in medical isotope production, will showcase its innovative capabilities for producing non-carrier-added lutetium-177 (n.c.a Lu-177), a radioisotope used in targeted cancer treatments, at the 7th Theranostic World Congress (TWC), March 22-24 in Santiago, Chile.
  • Lu-177.
  • Lu-177.
  • SHINE invites attendees to visit Booth A13 to learn more about its industry-leading production capabilities for n.c.a Lu-177.

Hot Chili and Los Losas Port Execute a MOU to Negotiate Binding Port Services Agreement for Costa Fuego

Retrieved on: 
Thursday, March 14, 2024

"We are pleased to be a joint funding partner with PLL for this feasibility study and the five-year optionality that this MOU provides Hot Chili, to negotiate a binding port services agreement as a foundation bulk concentrate customer at Las Losas.

Key Points: 
  • "We are pleased to be a joint funding partner with PLL for this feasibility study and the five-year optionality that this MOU provides Hot Chili, to negotiate a binding port services agreement as a foundation bulk concentrate customer at Las Losas.
  • Importantly, the MOU with PLL provides Hot Chili the right, for up to five years, to negotiate a binding Port Services Agreement for Costa Fuego.
  • The potential Port Service Agreement would include a "Take or Pay Volume" clause, based on at least 80% of Costa Fuego's projected future annual concentrate production.
  • Hot Chili will fund 20% of the port Feasibility Study, which is estimated to cost approximately US$4.6 million and take approximately two years to complete.

Canadian Solar Reports Fourth Quarter and Full Year 2023 Results

Retrieved on: 
Thursday, March 14, 2024

GUELPH, ON, March 14, 2024 /PRNewswire/ -- Canadian Solar Inc. ("Canadian Solar" or the "Company") (NASDAQ: CSIQ) today announced financial results for the fourth quarter and full year ended December 31, 2023.

Key Points: 
  • GUELPH, ON, March 14, 2024 /PRNewswire/ -- Canadian Solar Inc. ("Canadian Solar" or the "Company") (NASDAQ: CSIQ) today announced financial results for the fourth quarter and full year ended December 31, 2023.
  • Total operating expenses in the fourth quarter of 2023 were $213 million, compared to $225 million in the third quarter of 2023 and $213 million in the fourth quarter of 2022.
  • Depreciation and amortization charges in the fourth quarter of 2023 were $89 million, compared to $76 million in the third quarter of 2023 and $50 million in the fourth quarter of 2022.
  • Net interest expense in the fourth quarter of 2023 was $18 million, compared to $11 million in the third quarter of 2023 and $11 million in the fourth quarter of 2022.

Electric Tractor Market worth $3.4 billion by 2030 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Wednesday, March 13, 2024

>100 KWh is the fastest-growing battery capacity segment for the electric tractor market.

Key Points: 
  • >100 KWh is the fastest-growing battery capacity segment for the electric tractor market.
  • Moreover, a German startup named Tadus also showcased their prototype, E-Traktor, in August 2023, an electric battery tractor with a battery capacity of 130 kWh.
  • CNH Industrial developed the tractor in collaboration with Monarch Tractor, a California-based tractor manufacturer focusing on electrification and autonomy.
  • In August 2023, Solectac launched the eUT+ Narrow electric tractor, a zero-emission electric tractor.

Electric Tractor Market worth $3.4 billion by 2030 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Wednesday, March 13, 2024

>100 KWh is the fastest-growing battery capacity segment for the electric tractor market.

Key Points: 
  • >100 KWh is the fastest-growing battery capacity segment for the electric tractor market.
  • Moreover, a German startup named Tadus also showcased their prototype, E-Traktor, in August 2023, an electric battery tractor with a battery capacity of 130 kWh.
  • CNH Industrial developed the tractor in collaboration with Monarch Tractor, a California-based tractor manufacturer focusing on electrification and autonomy.
  • In August 2023, Solectac launched the eUT+ Narrow electric tractor, a zero-emission electric tractor.

Multi X Expands its Ultra-Premium, Antibiotic-Free ArkA Salmon Products to U.S. Fine Dining and Retail Markets

Retrieved on: 
Tuesday, March 12, 2024

To celebrate the expansion of ArkA's fresh, frozen and smoked salmon products to U.S. fine dining and retailers, Multi X hosted a special tasting experience for attendees during the Seafood Expo North America (SENA), March 10-12, 2024, at booth #841.

Key Points: 
  • To celebrate the expansion of ArkA's fresh, frozen and smoked salmon products to U.S. fine dining and retailers, Multi X hosted a special tasting experience for attendees during the Seafood Expo North America (SENA), March 10-12, 2024, at booth #841.
  • ArkA's salmon products are ABF certified, Aquaculture Stewardship Council (ASC) certified, and Best Aquaculture Practices (BAP) 4 Star certified.
  • There is a need in fine dining for ultra-premium, antibiotic-free Antarctic salmon and Arka is the solution.
  • Other products from the Multi X family including Multi X Lightly Smoked Salmon, Latitude 45 Smoked Salmon Candy Bites and Latitude 45 Smoked Chipotle Salmon, were featured in SENA's New Product Showcase, in a sampling at the Sand Bar, and at the Multi X booth throughout the three-day event.

Zdeněk Sobotka's SOLEK is building its largest solar power plant Leyda. It will generate almost 200 GWh of green energy annually

Retrieved on: 
Tuesday, March 12, 2024

PRAGUE, March 12, 2024 /PRNewswire/ -- SOLEK, the company of Czech renewable energy pioneer Zdeněk Sobotka, is building its largest project to date.

Key Points: 
  • PRAGUE, March 12, 2024 /PRNewswire/ -- SOLEK, the company of Czech renewable energy pioneer Zdeněk Sobotka, is building its largest project to date.
  • The new plant will significantly contribute to the decarbonisation goals of the country representing an advance renewable energy market.
  • SOLEK is a leading energy company engaged in the design, construction and operation of solar power plants in Europe and Latin America.
  • By the end of 2023, the entire SOLEK Group had 486 MW of solar power plants connected or under construction.

Zdeněk Sobotka's SOLEK is building its largest solar power plant Leyda. It will generate almost 200 GWh of green energy annually

Retrieved on: 
Tuesday, March 12, 2024

PRAGUE, March 12, 2024 /PRNewswire/ -- SOLEK, the company of Czech renewable energy pioneer Zdeněk Sobotka, is building its largest project to date.

Key Points: 
  • PRAGUE, March 12, 2024 /PRNewswire/ -- SOLEK, the company of Czech renewable energy pioneer Zdeněk Sobotka, is building its largest project to date.
  • The new plant will significantly contribute to the decarbonisation goals of the country representing an advance renewable energy market.
  • SOLEK is a leading energy company engaged in the design, construction and operation of solar power plants in Europe and Latin America.
  • By the end of 2023, the entire SOLEK Group had 486 MW of solar power plants connected or under construction.

Genprex Receives Notice of Patent Grant for Korean Patent Claiming Reqorsa® Immunogene Therapy with PD-1 and PD-L1 Antibodies to Treat Cancers

Retrieved on: 
Tuesday, March 12, 2024

AUSTIN, Texas, March 12, 2024 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that the Korean Patent Office has issued a Notice of Patent Grant for a broad patent that covers the use of Genprex's lead drug candidate, Reqorsa® Immunogene Therapy, in combination with anti-PD-1 and PD-L1 antibodies through 2037.

Key Points: 
  • These patents are applicable to Genprex's Acclaim-2 and Acclaim-3 clinical trials.
  • Genprex expects to complete enrollment in the Phase 1 dose escalation portion of the Acclaim-2 study in the second half of 2024.
  • The Acclaim-3 study has two portions - a Phase 1 dose escalation portion and a Phase 2 expansion portion.
  • Genprex was granted FDA Fast Track Designation and Orphan Drug Designation for the Acclaim-3 patient population.

Hiring Confidence Dips as Employers Weather Economic Headwinds

Retrieved on: 
Tuesday, March 12, 2024

MILWAUKEE, March 12, 2024 /PRNewswire/ -- Employer hiring intentions continue to moderate for the second quarter of 2024. According to the latest ManpowerGroup Employment Outlook Survey, the Net Employment Outlook (NEO) stands at +22% for Q2, down -2% year-over-year and -4% from Q1. The research is based on data collected from more than 40,000 employers in 42 countries between January 2-31, 2024.

Key Points: 
  • The survey found the IT sector has the highest hiring Outlook globally, followed by Financials & Real Estate, and Healthcare & Life Sciences.
  • MILWAUKEE, March 12, 2024 /PRNewswire/ -- Employer hiring intentions continue to moderate for the second quarter of 2024.
  • The research is based on data collected from more than 40,000 employers in 42 countries between January 2-31, 2024.
  • Employers in the U.S. (+34%) reported the strongest hiring intentions, followed by Canada (+22%), and Puerto Rico (+14%).